KP
GILD icon

Kiltearn Partners’s Gilead Sciences GILD Stock Holding History

Kiltearn Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12M Sell
94,871
-5,529
-6% -$728K 2.91% 12
2026
Q1 		$14M Sell
100,400
-20,900
-17% -$2.93M 3.76% 13
2025
Q4 		$14.9M Sell
121,300
-24,500
-17% -$2.98M 3.23% 13
2025
Q3 		$16.2M Buy
145,800
+11,400
+8% +$1.3M 3.24% 11
2025
Q2 		$14.9M Sell
134,400
-11,600
-8% -$1.23M 3% 12
2025
Q1 		$16.4M Sell
146,000
-4,900
-3% -$506K 3.12% 11
2024
Q4 		$13.9M Buy
150,900
+78,300
+108% +$7.05M 2.3% 20
2024
Q3 		$6.09M Buy
+72,600
New +$5.54M 0.83% 30
2020
Q2 		– Sell
-439,800
Closed -$32.9M – 28
2020
Q1 		$32.9M Sell
439,800
-168,900
-28% -$11.7M 2.18% 22
2019
Q4 		$39.6M Buy
+608,700
New +$39.6M 1.49% 24

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kiltearn Partners's GILD Position: Q2 2026 in Review

Kiltearn Partners reduced its Gilead Sciences (GILD) stake by 5.5% in Q2 2026, selling an estimated $728K and leaving 94,871 shares worth $12M. The position accounts for 2.91% of the portfolio, ranked #12.

Kiltearn Partners first reported a position in GILD in Q4 2019 and has held it in 10 quarters since. The position peaked at $39.6M in Q4 2019. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Kiltearn Partners held 94,871 shares of Gilead Sciences worth $12M as of Q2 2026.
  • Kiltearn Partners sold 5,529 Gilead Sciences shares in Q2 2026, an estimated $728K.
  • Gilead Sciences made up 2.91% of Kiltearn Partners's portfolio in Q2 2026, its #12 holding.
  • Kiltearn Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 10 quarters since.
  • Kiltearn Partners's Gilead Sciences position peaked at $39.6M in Q4 2019.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Kiltearn Partners's 13F filing for Q2 2026, filed 12 Aug 2026.